Works matching IS 25155091 AND DT 2023 AND VI 7 AND IP 2
Results: 17
Breast exam use during the protracted COVID-19 pandemic, by age, race, and geography.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad025
- By:
- Publication type:
- Article
In utero exposure to antiemetic and risk of adult-onset colorectal cancer.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad021
- By:
- Publication type:
- Article
"Move more, sit less" is a feasible and impactful guideline for improving cancer survival.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
A predictive model for lung cancer screening nonadherence in a community setting health-care network.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad019
- By:
- Publication type:
- Article
Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad017
- By:
- Publication type:
- Article
Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad016
- By:
- Publication type:
- Article
Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad015
- By:
- Publication type:
- Article
p27<sup>Kip1</sup> V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancer.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad014
- By:
- Publication type:
- Article
Double-blinded is not better than "mutually enlightened": implications of Lord-Besson et al.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD study.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad011
- By:
- Publication type:
- Article
Human papillomavirus–associated cancer incidence by disaggregated Asian American, Native Hawaiian, and other Pacific Islander ethnicity.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad012
- By:
- Publication type:
- Article
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad010
- By:
- Publication type:
- Article
Recent trends of "manels": gender representation among invited panelists at an international oncology conference.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad008
- By:
- Publication type:
- Article
Prospective associations between accelerometry-derived physical activity and sedentary behaviors and mortality among cancer survivors.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad007
- By:
- Publication type:
- Article
Allostatic load and cardiovascular outcomes in males with prostate cancer.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad005
- By:
- Publication type:
- Article
Investigating the racial gap in prostate cancer screening with prostate-specific antigen among younger men from 2012 to 2020.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad003
- By:
- Publication type:
- Article
Assessing the impact of open-label designs in patient-reported outcomes: investigation in oncology clinical trials.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad002
- By:
- Publication type:
- Article